This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Immune Design Corp., Immune Designcorp.. Active years: 2012-2021.
Company Filing History:
Years Active: 2012-2021
Title: Christopher James Nicolai: Innovator in Lentiviral Vector Technology
Introduction
Christopher James Nicolai is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of lentiviral vector particles. With a total of four patents to his name, Nicolai's work has advanced the understanding and application of viral vectors in research and therapeutic settings.
Latest Patents
Nicolai's latest patents focus on materials and methods for producing improved lentiviral vector particles. These innovations include methods useful for generating highly mannosylated pseudotyped lentiviral vector particles that comprise a Vpx protein. His work in this area is crucial for enhancing the efficacy of gene delivery systems.
Career Highlights
Throughout his career, Nicolai has worked with notable companies, including Immune Design Corporation. His experience in these organizations has allowed him to refine his expertise in viral vector technology and contribute to groundbreaking research.
Collaborations
Nicolai has collaborated with Semih Ullah Tareen, further expanding the impact of his work in the field. Their partnership has likely fostered innovative approaches to the challenges faced in biotechnology.
Conclusion
Christopher James Nicolai is a key figure in the development of lentiviral vector technology, with a strong patent portfolio and valuable industry experience. His contributions continue to shape the future of gene therapy and biotechnology.